Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07099417 Sponsor: I.M. Sechenov First Moscow State Medical University Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT07099417
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have given written agreement to take part in the study
  • People who are being seen as outpatients or are admitted to a participating research centre

Who may not be able to join:

  • People who do not wish to take part in the study
  • People whose ECG (heart tracing) recording comes out too poor in quality to be useful on the single-channel monitor used in the study
  • People whose heart cannot be clearly seen during an ultrasound (echocardiography) examination
  • People who experience a sudden acute mental health episode (psychotic reaction) during the course of the study
  • People whose long-term (chronic) health condition flares up in a way that requires a change in their treatment and prevents them from continuing in the study
  • People with conditions that may interfere with ECG recording quality, such as Parkinson's disease or essential tremor (uncontrolled shaking)
  • People with a diagnosed mental illness
  • People who have a pacemaker fitted
  • People who have an artificial (prosthetic) heart valve

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philipp Kopylov, Prof., I.M. Sechenov First Moscow State Medical University (Sechenov University)

Phone: +79164778724

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
I.M. Sechenov First Moscow State Medical University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Parameters of single-channel ECG that have a reliable correlation with the presence of valvular heart defects; Determination of sensitivity of valvular heart defects of multivariate models for analyzing single-channel electrocardiogram data; Determination of specificity of valvular heart defects of multivariate models for analyzing single-channel electrocardiogram data; Determination of diagnostic accuracy of valvular heart defects of multivariate models for analyzing single-channel electrocardiogram data

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov